Cantor Fitzgerald’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Cantor Fitzgerald’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-552,466	Closed	-$5.6M	–	832
2022 Q3	$5.6M	Sell	552,466 -900,000	-62%	-$9.09M	0.12%	214
2022 Q2	$14.6M	Buy	1,452,466 +1,102,466	+315%	+$11.1M	0.28%	111
2022 Q1	$3.5M	Buy	+350,000	New	+$3.5M	0.26%	101

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cantor Fitzgerald's ARCK Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 552,466 shares — an estimated $5.6M sold.

Cantor Fitzgerald first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $14.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Cantor Fitzgerald reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Cantor Fitzgerald sold 552,466 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $5.6M.
Cantor Fitzgerald first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Cantor Fitzgerald's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $14.6M in Q2 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.